Actively Recruiting
Technological and Patient-tailored Innovations for Maximizing Effectiveness of Cardiac Arrest Resuscitation
Led by Università Vita-Salute San Raffaele · Updated on 2025-08-06
500
Participants Needed
3
Research Sites
83 weeks
Total Duration
On this page
Sponsors
U
Università Vita-Salute San Raffaele
Lead Sponsor
I
IRCCS Ospedale San Raffaele
Collaborating Sponsor
AI-Summary
What this Trial Is About
Out-of-hospital cardiac arrest (OHCA) affects 275,000 people in Europe every year. In Italy alone, 50,000 people experience OHCA annually, with only 9% surviving. Half of the survivors suffer severe brain damage. Immediate CPR and defibrillation by bystanders before the ambulance arrives can save lives, but often, CPR starts only when the ambulance gets there. Additionally, half of all OHCAs occur when the person is alone, causing delays in recognizing the emergency, calling for help, and starting lifesaving actions. Effective chest compressions and defibrillation are crucial but are often not done correctly or are not customized for each patient. Current guidelines recommend the same approach for everyone, which doesn't consider individual needs. To tackle these issues, we plan to develop artificial intelligence (AI) algorithms, smartphone apps, and new devices. Our main goal is to create tools and technologies to improve the recognition of OHCA and provide timely and effective interventions, ultimately reducing the impact of OHCA and improving survival rates. First, we aim to create an AI algorithm that can predict major cardiovascular events like heart attacks or cardiac arrests minutes, hours, or days before they happen. We will collect data from wearable devices to train and validate this algorithm, helping us identify individuals at risk. By alerting these individuals, they can seek emergency care and receive treatment before a cardiac arrest occurs. We will also work on recognizing OHCA cases from surveillance camera footage when they happen to people who are alone. Second, to increase the rate of CPR and defibrillation before ambulances arrive, we will develop a smartphone app that geolocates and alerts nearby citizens to act as first responders. The app will guide them on how to quickly find a defibrillator and use it. Third, to find the best spots on the chest for compressions and defibrillation, we will study chest scans from CTs and echocardiograms in both elective patients and cardiac arrest victims. This will help us understand the effects of compressing different heart structures and develop a sensor to determine the optimal positions for compressions and defibrillator pads. Our multidisciplinary team of clinicians, researchers, and engineers will conduct experimental, simulation, and observational studies to develop these technologies, evaluate their potential for patents, design a plan for their use, and test their effectiveness in preventing and recognizing OHCA. We believe that by improving each step in the chain of survival-preventing cardiac events, early recognition, timely CPR and defibrillation, and high-quality advanced resuscitation-we can significantly improve treatment times and reduce the global death and disability rates caused by OHCA.
CONDITIONS
Official Title
Technological and Patient-tailored Innovations for Maximizing Effectiveness of Cardiac Arrest Resuscitation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18-70 years for prediction study participants
- Healthy volunteers or patients who experienced major cardiovascular events
- Users of smartwatches or smartphones that continuously collect health data
- Adults aged 18 years or older who had non-traumatic cardiac arrest treated with chest compressions
- Patients who received transesophageal echocardiogram, chest X-ray, or chest CT scan after cardiac arrest
- Adults aged 18 years or older who received a chest CT scan for any reason
- Provided informed consent
You will not qualify if you...
- Unable to access or export wearable device data
- Not wearing the wearable device for more than 24 hours at a time
- Not wearing the wearable device in the 4 weeks before the cardiac event
- Patients with severe deformity of the chest or mediastinum
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
IRCCS Ospedale San Raffaele
Milan, Italy, 20132
Actively Recruiting
2
AOU Policlinico Federico II
Naples, Italy, 80100
Not Yet Recruiting
3
Azienda Ospedaliera Universitaria Vanvitelli
Naples, Italy, 80138
Not Yet Recruiting
Research Team
G
Giovanni Landoni, MD
CONTACT
T
Tommaso Scquizzato, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here